WNT10B and hepatocellular carcinoma: In HCC, LINC00355 upregulates the expression of WNT10B by inhibiting miR‐6777‐3p at the posttranscriptional level and it activates the Wnt/β‐catenin signaling pathway to promote malignant cell behavior [15].